Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

About the Cover

September 1, 2019; Volume 60,Issue Supplement 2

Driving the Future of Nuclear Medicine

  • You have access
    Driving the Future of Nuclear Medicine
    Ken Herrmann, Patrick Veit-Haibach and Wolfgang A. Weber
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 1S-2S; DOI: https://doi.org/10.2967/jnumed.119.232264
  • FEATURED ARTICLE

    • You have access
      The Future of Nuclear Medicine as an Independent Specialty
      Johannes Czernin, Ida Sonni, Aria Razmaria and Jeremie Calais
      Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 3S-12S; DOI: https://doi.org/10.2967/jnumed.118.220558
  • You have access
    Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine
    Thomas Langbein, Wolfgang A. Weber and Matthias Eiber
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 13S-19S; DOI: https://doi.org/10.2967/jnumed.118.220566
  • You have access
    Nuclear Medicine and Wall Street: An Evolving Relationship
    Mike Sherman and Rachel Levine
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 20S-24S; DOI: https://doi.org/10.2967/jnumed.118.220798
  • You have access
    Do You Want an Inspirational Career? Choose Nuclear Medicine
    Steven M. Larson
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 25S-28S; DOI: https://doi.org/10.2967/jnumed.118.220574
  • You have access
    Artificial Intelligence in Nuclear Medicine
    Felix Nensa, Aydin Demircioglu and Christoph Rischpler
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 29S-37S; DOI: https://doi.org/10.2967/jnumed.118.220590
  • You have access
    Radiomics: Data Are Also Images
    Mathieu Hatt, Catherine Cheze Le Rest, Florent Tixier, Bogdan Badic, Ulrike Schick and Dimitris Visvikis
    Journal of Nuclear Medicine September 1, 2019, 60 (Supplement 2) 38S-44S; DOI: https://doi.org/10.2967/jnumed.118.220582
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 60 (Supplement 2)
Journal of Nuclear Medicine
Vol. 60, Issue Supplement 2
September 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Driving the Future of Nuclear Medicine
    • FEATURED ARTICLE
  • Most Cited
  • Most Read
Loading
  • First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
  • Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
  • Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
  • Oliver Sartor Talks with Thomas A. Hope, Jeremie Calais, and Wolfgang P. Fendler About FDA Approval of PSMA
  • Fibroblast Activation Protein–Targeted PET/CT with 68Ga-FAPI for Imaging IgG4-Related Disease: Comparison to 18F-FDG PET/CT
More...
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire